399 South 34th Street
Suite 2002 Penn Tower

Philadelphia, PA 19104

Phone: (215) 662-2560
Fax: (215) 349-8312

Media Contact
(for this release only)

Karen Kreeger
(215) 349-5658

April 18, 2005

Penn Researchers Determine Structure of Binding Site of Colon-Cancer Drug and Its Protein Target
Finding Will Steer Future Treatment Design

Schematic showing how Erbitux takes the place of the EGFR growth factor, thereby inhibiting cancerous growth.

Image courtesy of Kate Ferguson and Cancer Cell.

<< Photo Gallery Index

<< Related Article
Privacy Policy Disclaimer Terms of Use